FDA Updates Guidance On ANDAs During COVID
Source : 'Generics Bulletin'
A US Food and Drug Administration question-and-answer document on the development of abbreviated new drug applications during the COVID-19 pandemic has today been updated by the agency to offer additional...
The Big Health Care Conundrum: How To Sustainably Unlock The Value Of Diagnostics
Source : IN VIVO
It is never a bad time to spotlight the value of early and effective diagnosis, the benefits of which extend far beyond the innovator, beyond individual patients and to national...
Fresh Australian Industry Pact Will Insure Against Shortages
Source : 'Generics Bulletin'
A new five-year strategic agreement running from mid-2022 to 2027 has been finalized between Australia’s government and the country’s Generic and Biosimilar Medicines Association, offering “improved stability, predictability and viability”...
Pandemic ‘Dividend’ Must Not Be Squandered
Source : IN VIVO
The shock of COVID-19 led many device and diagnostics companies to pivot, rapidly and successfully, to a response mode and then to medium-term coping mechanisms. They learnt much about the...